Focus Forward: Invest in Yourself, Invest in Your Staff

| 01 April 2010

A few weeks ago, the Tufts University Center for the Study of Drug Development released findings from its study on drug development and biotechnology organizations. The group's conclusions: "The growing volume of global drug development and commercialization activity during the past decade dramatically increased the workload for regulatory affairs professionals at pharmaceutical and biotech companies. " The Tufts study reported that regulatory professionals support an average of 100 projects per year, are often more experienced than their peers in other areas and have longer tenure with the organization. The study also indicated that challenges for regulatory professionals are likely to increase while their role will be even more critical.

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy